Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats

Chen,Ming; Long,Zijiang; Wang,Yajuan; Liu,Jinlin; Pian,Hai; Wang,Liang; Chen,Zhiwu

doi:10.3892/etm.2012.856

February 2013 Volume 5 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February 2013 Volume 5 Issue 2

Full Size Image

Article

Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats

Authors:
- Ming Chen
- Zijiang Long
- Yajuan Wang
- Jinlin Liu
- Hai Pian
- Liang Wang
- Zhiwu Chen
View Affiliations / Copyright

Affiliations: Department of Pharmacology, Integrative Medicine Clinical College, Anhui University of Traditional Chinese Medicine, Anhui 230032, P.R. China, Department of Pharmacology, Integrative Medicine Clinical College, Anhui University of Traditional Chinese Medicine, Anhui 230032, P.R. China, Department of Pharmacology, Anqing Medicine College, Anqing, Anhui 246052, P.R. China, Department of Pharmacology, Basic Medical College, Anhui Medical University, Hefei, Anhui 230032, P.R. China
Pages: 429-432
|
Published online on: December 11, 2012

https://doi.org/10.3892/etm.2012.856
Expand metrics +

Abstract

The present study was undertaken to investigate the protective effects of saponin on a hypertensive target organ (the kidney) in spontaneously hypertensive rats (SHRs) and also to explore the effect of saponin on the renin‑angiotensin‑aldosterone system (RAAS). A total of 24, 14‑week‑old SHRs were randomly divided into three groups; the first was administered low‑dose saponin, the second with high‑dose saponin and the third with a placebo as the control group. An additional eight healthy male Wistar rats were used as the normal group. The blood pressures (BPs) of the rats were determined using an animal BP‑6 non‑invasive blood pressure tester. Furthermore, the gene expression of TGFB1, collagen I and prorenin receptor (PRR) was determined by quantitative real time (qRT)‑PCR. The histopathological and morphological features of the tissue samples were assessed semi‑quantitatively. The content of saponin in the renal samples was lower in SHRs than in the normal healthy rats, but the plasma levels of saponin were similar. Mean arterial pressure (MAP) was reduced 5 days subsequent to saponin treatment by 36±3 and 51±4 mmHg in the low‑ and high‑dose saponin groups, respectively. The anti‑hypertensive effect of saponin was dose‑related during the first 4 weeks of treatment. The gene expression of TGFB1 and collagen I in the renal samples was significantly suppressed in the low‑ and high‑dose saponin groups compared with that in the control group. The gene expression of PRR was significantly and dose‑dependently increased in the saponin‑treated groups. These findings suggested that saponin reduced systemic BP and blocked the circulating and tissue RAAS.

View Figures

View References

1.	Delcayre C and Swynghedauw B: Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol. 34:1577–1584. 2002. View Article : Google Scholar : PubMed/NCBI
2.	Weber KT: Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation. 96:4065–4082. 1997. View Article : Google Scholar : PubMed/NCBI
3.	Urata H, Nishimura H, Ganten D and Arakawa K: Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases. Blood Press Suppl. 2:22–28. 1996.PubMed/NCBI
4.	Olivetti G, Capasso JM, Sonnenblick EH and Anversa P: Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res. 67:23–34. 1990. View Article : Google Scholar : PubMed/NCBI
5.	Zannad F, Alla F, Dousset B, et al: Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators Circulation. 102:2700–2706. 2000. View Article : Google Scholar
6.	Bauersachs J and Fraccarollo D: Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Minerva Cardioangiol. 51:155–164. 2003.PubMed/NCBI
7.	Jorde UP, Vittorio T, Katz SD, et al: Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation. 106:1055–1057. 2002. View Article : Google Scholar
8.	McKelvie RS, Yusuf S, Pericak D, et al: Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation. 100:1056–1064. 1999. View Article : Google Scholar
9.	Kodavanti UP, Schladweiler MC, Ledbetter AD, et al: The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter. Toxicol Appl Pharmacol. 164:250–263. 2000. View Article : Google Scholar
10.	Sagvolden T: Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention- deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev. 24:31–39. 2000. View Article : Google Scholar : PubMed/NCBI
11.	Singh VP, Le B, Bhat VB, et al: High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol. 293:H939–H948. 2007. View Article : Google Scholar : PubMed/NCBI
12.	de Zeeuw D, Remuzzi G, Parving HH, et al: Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 65:2309–2320. 2004.PubMed/NCBI
13.	Border WA and Noble NA: Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension. 31:181–188. 1998. View Article : Google Scholar : PubMed/NCBI
14.	Ichihara A, Hayashi M, Kaneshiro Y, et al: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the ‘handle’ region for nonproteolytic activation of prorenin. J Clin Invest. 114:1128–1135. 2004.PubMed/NCBI
15.	Ichihara A, Suzuki F, Nakagawa T, et al: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 17:1950–1961. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Burcklé CA, Jan Danser AH, Müller DN, et al: Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension. 47:552–556. 2006.PubMed/NCBI
17.	Nguyen G, Delarue F, Burcklé C, et al: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 109:1417–1427. 2002. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles